BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kløve S, Genger C, Weschka D, Mousavi S, Bereswill S, Heimesaat MM. Toll-Like Receptor-4 Is Involved in Mediating Intestinal and Extra-Intestinal Inflammation in Campylobacter coli-Infected Secondary Abiotic IL-10-/- Mice. Microorganisms 2020;8:E1882. [PMID: 33261211 DOI: 10.3390/microorganisms8121882] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Du K, Foote MS, Mousavi S, Buczkowski A, Schmidt S, Bereswill S, Heimesaat MM. Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice. Microorganisms 2022;10:1953. [PMID: 36296229 DOI: 10.3390/microorganisms10101953] [Reference Citation Analysis]
2 Rong Z, Huang Y, Cai H, Chen M, Wang H, Liu G, Zhang Z, Wu J. Gut Microbiota Disorders Promote Inflammation and Aggravate Spinal Cord Injury Through the TLR4/MyD88 Signaling Pathway. Front Nutr 2021;8:702659. [PMID: 34589510 DOI: 10.3389/fnut.2021.702659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Corcionivoschi N, Gundogdu O. Foodborne Pathogen Campylobacter. Microorganisms 2021;9:1241. [PMID: 34200984 DOI: 10.3390/microorganisms9061241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Weschka D, Mousavi S, Biesemeier N, Bereswill S, Heimesaat MM. Survey of Pathogen-Lowering and Immuno-Modulatory Effects Upon Treatment of Campylobacter coli-Infected Secondary Abiotic IL-10-/- Mice with the Probiotic Formulation Aviguard®. Microorganisms 2021;9:1127. [PMID: 34070972 DOI: 10.3390/microorganisms9061127] [Reference Citation Analysis]